Pharmaceutical Business review

Kane Biotech closes $1.55 million private placement

Each unit is comprised of one common share of the company and one-half of one share purchase warrant. Each whole warrant entitles the holder thereof to purchase one share at a price of $0.40 for a period of eighteen months from the date of issuance of the warrant. The net proceeds of the offering shall be used for R&D and working capital purposes.